Japan grants $1.3bn in new subsidies to bolster domestic flu vaccine capacity
This article was originally published in Scrip
Executive Summary
Having learnt a lesson from past problems, Japan is looking to build up its national manufacturing capacity for H1N1 influenza vaccines through a new round of government grants to several major domestic producers, including Takeda and Daiichi Sankyo.